Refractory schizophrenia and atypical antipsychotics

@article{Taylor2000RefractorySA,
  title={Refractory schizophrenia and atypical antipsychotics},
  author={David McDonald Taylor and Denise Duncan-McConnell},
  journal={Journal of Psychopharmacology},
  year={2000},
  volume={14},
  pages={409 - 418}
}
Treatment resistant or refractory schizophrenia is a difficult to define condition of largely unknown prevalence. For 10 years, clozapine has been the standard treatment in this condition and is recognized unequivocally as being effective. However, clozapine is sometimes poorly tolerated and has the potential for severe toxicity. Partly as a result of this, other atypicals have recently been evaluated as treatments for refractory schizophrenia. In order to evaluate the evidence base relating to… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 29 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 62 REFERENCES

Place of olanzapine in therapy

M Launer
  • Pharmaceut J
  • 1998
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Treatment-resistant schizophrenia--the role of clozapine.

  • Current medical research and opinion
  • 1997
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Clozapine in the treatment of 121 out-patients

VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL